Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Markus

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|March 1, 1987
Plasminogen activator content of gynecological tumors and their metastasesS M Camiolo, G Markus, M S Piver
The Journal of Biological Chemistry|February 10, 1978
Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogenG Markus, J L DePasquale, F C Wissler
The Journal of Biological Chemistry|February 10, 1978
Comparison of some properties of native (Glu) and modified (Lys) human plasminogenG Markus, J L Evers, G H Hobika
The Journal of Biological Chemistry|May 25, 1982
Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer caseS Harvey, J Minowada, H Takita, et al.
Cancer Research|April 1, 1985
Localization of plasminogen activators in human colon cancer by immunoperoxidase stainingS Kohga, S R Harvey, R M Weaver, et al.
Kardiologiia|January 1, 1985
[Baroreceptor reflexes after exposure to the hypotensive action of prazosin blocking postsynaptic alpha 1-adrenergic receptors]S Manucharov, A Brattstrem, R Staak, et al.
Journal of Surgical Oncology|October 1, 1986
Aminocaproic acid (AMICAR) in advanced colorectal carcinomaN J Petrelli, G Markus, L Herrera, et al.
Thrombosis Research|March 1, 1980
Augmentation of streptokinase activator activity by fibrinogen or fibrinS M Camiolo, G Markus, J L Evers, et al.
Cancer Research|November 1, 1983
Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumorsG Markus, S M Camiolo, S Kohga, et al.
Journal of Medicine|January 1, 1994
Potentiation of thrombolytic therapy by enzyme combinations and with aspirin or pentoxifyllineJ L Ambrus, C M Ambrus, S Stadler, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|March 1, 1987
Plasminogen activator content of gynecological tumors and their metastasesS M Camiolo, G Markus, M S Piver
The Journal of Biological Chemistry|February 10, 1978
Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogenG Markus, J L DePasquale, F C Wissler
The Journal of Biological Chemistry|February 10, 1978
Comparison of some properties of native (Glu) and modified (Lys) human plasminogenG Markus, J L Evers, G H Hobika
The Journal of Biological Chemistry|May 25, 1982
Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer caseS Harvey, J Minowada, H Takita, et al.
Cancer Research|April 1, 1985
Localization of plasminogen activators in human colon cancer by immunoperoxidase stainingS Kohga, S R Harvey, R M Weaver, et al.
Kardiologiia|January 1, 1985
[Baroreceptor reflexes after exposure to the hypotensive action of prazosin blocking postsynaptic alpha 1-adrenergic receptors]S Manucharov, A Brattstrem, R Staak, et al.
Journal of Surgical Oncology|October 1, 1986
Aminocaproic acid (AMICAR) in advanced colorectal carcinomaN J Petrelli, G Markus, L Herrera, et al.
Thrombosis Research|March 1, 1980
Augmentation of streptokinase activator activity by fibrinogen or fibrinS M Camiolo, G Markus, J L Evers, et al.
Cancer Research|November 1, 1983
Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumorsG Markus, S M Camiolo, S Kohga, et al.
Journal of Medicine|January 1, 1994
Potentiation of thrombolytic therapy by enzyme combinations and with aspirin or pentoxifyllineJ L Ambrus, C M Ambrus, S Stadler, et al.
Pageof 5